Synairgen plc (LON:SNG – Get Rating)'s stock price passed below its 200-day moving average during trading on Friday . The stock has a 200-day moving average of GBX 34.78 ($0.42) and traded as low as GBX 21.08 ($0.25). Synairgen shares last traded at GBX 22 ($0.27), with a volume of 146,989 shares trading hands.

Synairgen Price Performance

The company has a current ratio of 5.82, a quick ratio of 5.69 and a debt-to-equity ratio of 0.09. The firm has a market cap of £44.30 million and a P/E ratio of -0.91. The company has a fifty day moving average price of GBX 27.53 and a two-hundred day moving average price of GBX 34.78.

About Synairgen

(Get Rating)

Synairgen plc discovers and develops drugs for respiratory diseases. It develops SNG001, an inhaled interferon beta for the treatment of COVID-19; inhaled interferon beta (IFN-ß), which is in Phase-II clinical trials for the treatment of asthma caused by the common cold and flu; IFN-ß that is in Phase-II clinical trials for the treatment or prevention of chronic obstructive pulmonary disease; and LOXL2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF) disease.

Featured Articles

• Why This Dip in Advanced Auto Parts May be an Opportunity
• MarketBeat: Week in Review 8/22 – 8/26
• Institutional Buying Put A Bottom In Marvell Technology
• Dell Stock Retreats On Weaker Sales, Falls Into Value Terrirtory
• 3 Reasons Dollar General's Rally Has Legs

Receive News & Ratings for Synairgen Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synairgen and related companies with MarketBeat.com's FREE daily email newsletter.